PUBLISHER: The Business Research Company | PRODUCT CODE: 1957684
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957684
Precision Oncology Global Market Report 2026
Precision oncology is a medical approach that customizes cancer treatment based on the unique characteristics of each patient. This strategy utilizes molecular and genetic profiling of tumors to identify specific mutations, biomarkers, or pathways driving cancer progression, enabling clinicians to choose targeted therapies that are more effective and less toxic compared with conventional treatments.
The main types of precision oncology include genomic sequencing and immunotherapy. Genomic sequencing involves determining the complete DNA sequence of an organism's genome at a given time. Product offerings in this area include genetic tests, biomarker-based tests, and targeted therapeutics, applied in treating various cancers such as breast, lung, colorectal, prostate, skin, stomach, and others. Supporting technologies include next-generation sequencing, bioinformatics, molecular imaging, and liquid biopsy. The primary end users are hospitals, research laboratories, pharmaceutical companies, and diagnostic centers.
Tariffs have impacted the precision oncology market by increasing costs of imported sequencing equipment, reagents, and biologic therapeutics. Segments such as genomic sequencing platforms, biomarker-based tests, and immunotherapy products are most affected, with North America, Europe, and Asia-Pacific regions reliant on imports facing higher operational costs. While tariffs have slowed supply chains and raised treatment costs, they have also encouraged local production, investment in domestic research infrastructure, and innovation in cost-effective precision oncology solutions.
The precision oncology market research report is one of a series of new reports from The Business Research Company that provides precision oncology market statistics, including precision oncology industry global market size, regional shares, competitors with a precision oncology market share, detailed precision oncology market segments, market trends and opportunities, and any further data you may need to thrive in the precision oncology industry. This precision oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The precision oncology market size has grown rapidly in recent years. It will grow from $106.21 billion in 2025 to $117.67 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to limited availability of genomic sequencing technologies, reliance on conventional chemotherapy, increasing cancer prevalence globally, early adoption of immunotherapy, growing research in molecular oncology.
The precision oncology market size is expected to see rapid growth in the next few years. It will grow to $175.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to development of next-generation sequencing platforms, increasing integration of bioinformatics and AI in oncology, rising adoption of liquid biopsy and molecular imaging, expansion of personalized treatment options, growth of research collaborations between hospitals and pharmaceutical companies. Major trends in the forecast period include expansion of targeted cancer therapies based on molecular profiling, increasing adoption of liquid biopsy and non-invasive diagnostic methods, growth in biomarker-based testing for personalized treatment plans, rising integration of immunotherapy with genomic sequencing, enhanced focus on rare and hard-to-treat cancer types.
The heightened recognition and pivot to personalized therapies is set to boost the precision oncology market ahead. Personalized therapies adapt to a patient's genetics, markers, and disease traits for sharper efficacy and fewer downsides. Their growth flows from genomic tech strides that spot mutation drivers precisely, unlocking targeted fixes. Precision oncology propels personalized therapies via tumor genomic and molecular scans to customize cancer care to individual profiles. For example, in February 2023, GOV.UK announced the Health and Social Care Secretary's MoU with BioNTech SE to push cancer vaccine work in England, targeting 10,000 personalized doses for UK patients by 2030. Thus, the rising awareness and shift to personalized therapies is fueling the precision oncology market.
Top companies in the precision oncology market are pioneering methods like molecular tumor boards to guide bespoke decisions by blending genomic data with clinical insights. A molecular tumor board is an expert team reviewing intricate genomic and molecular results to shape patient-specific cancer plans based on tumor specifics. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE healthcare network, launched a precision oncology clinic within three tailored cancer programs, harnessing data-led, gene-centric tactics. It crafts individualized therapies from tumor genetics, yielding pinpoint accuracy, better results, and slimmer side effects. This aligns treatments to unique cancer molecules, lifting survival, curbing harm, and enriching life quality.
In March 2024, Bayer AG, a Germany-based pharma leader, allied with Aignostics GmbH to elevate precision oncology using the latter's AI pathology and patient data for smarter cancer drug hunts. Aignostics GmbH is a Germany AI firm supplying tools honed for precision oncology.
Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The precision oncology market consists of revenues earned by entities by providing services such as genomic and molecular profiling services, companion diagnostics services, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision oncology market also includes sales of genomic and molecular diagnostic equipment, immune checkpoint inhibitors, and bioinformatics and decision support tools. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Precision Oncology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses precision oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for precision oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision oncology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
- Markets Covered:1) By Type: Genomic Sequencing; Immunotherapy
- 2) By Test Type: Genetic Tests; Biomarker-Based Tests; Therapeutics
- 3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Skin Cancer; Stomach Cancer; Other Cancers
- 4) By Technology: Next-Generation Sequencing; Bioinformatics; Molecular Imaging; Liquid Biopsy
- 5) By End-users: Hospitals; Research Laboratories; Pharmaceutical Companies; Diagnostic Centers
- Subsegments:
- 1) By Genomic Sequencing: Whole Genome Sequencing; Whole Exome Sequencing; Targeted Gene Sequencing
- 2) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Therapy
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; AstraZeneca plc.; Novartis AG; Amgen Inc.; Agilent Technologies Inc.; Illumina Inc.; Qiagen N.V.; Exact Sciences Corporation; NeoGenomics Laboratories Inc.; Myriad Genetics Inc.; Invitae Corporation; Caris Life Sciences; Foundation Medicine Inc.; NanoString Technologies Inc.; Personalis Inc.; Strata Oncology Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: Word, PDF or Interactive Report
- + Excel Dashboard
- Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
Table of Contents
1. Executive Summary
- 1.1. Key Market Insights (2020-2035)
- 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
- 1.3. Major Factors Driving the Market
- 1.4. Top Three Trends Shaping the Market
2. Precision Oncology Market Characteristics
- 2.1. Market Definition & Scope
- 2.2. Market Segmentations
- 2.3. Overview of Key Products and Services
- 2.4. Global Precision Oncology Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
- Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
- 2.4.4. Market Attractiveness Scoring and Interpretation
- 2.4.5. Strategic Implications and Recommendations
3. Precision Oncology Market Supply Chain Analysis
- 3.1. Overview of the Supply Chain and Ecosystem
- 3.2. List Of Key Raw Materials, Resources & Suppliers
- 3.3. List Of Major Distributors and Channel Partners
- 3.4. List Of Major End Users
4. Global Precision Oncology Market Trends And Strategies
- 4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.2. Major Trends
- 4.2.1 Expansion Of Targeted Cancer Therapies Based On Molecular Profiling
- 4.2.2 Increasing Adoption Of Liquid Biopsy And Non-Invasive Diagnostic Methods
- 4.2.3 Growth In Biomarker-Based Testing For Personalized Treatment Plans
- 4.2.4 Rising Integration Of Immunotherapy With Genomic Sequencing
- 4.2.5 Enhanced Focus On Rare And Hard-To-Treat Cancer Types
5. Precision Oncology Market Analysis Of End Use Industries
- 5.1 Hospitals
- 5.2 Research Laboratories
- 5.3 Pharmaceutical Companies
- 5.4 Diagnostic Centers
- 5.5 Oncology Specialty Clinics
6. Precision Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Precision Oncology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
- 7.1. Global Precision Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 7.2. Global Precision Oncology Market Size, Comparisons And Growth Rate Analysis
- 7.3. Global Precision Oncology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
- 7.4. Global Precision Oncology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Precision Oncology Total Addressable Market (TAM) Analysis for the Market
- 8.1. Definition and Scope of Total Addressable Market (TAM)
- 8.2. Methodology and Assumptions
- 8.3. Global Total Addressable Market (TAM) Estimation
- 8.4. TAM vs. Current Market Size Analysis
- 8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Precision Oncology Market Segmentation
- 9.1. Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Genomic Sequencing, Immunotherapy
- 9.2. Global Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Genetic Tests, Biomarker-Based Tests, Therapeutics
- 9.3. Global Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers
- 9.4. Global Precision Oncology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy
- 9.5. Global Precision Oncology Market, Segmentation By End-users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers
- 9.6. Global Precision Oncology Market, Sub-Segmentation Of Genomic Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing
- 9.7. Global Precision Oncology Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy
10. Precision Oncology Market Regional And Country Analysis
- 10.1. Global Precision Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- 10.2. Global Precision Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Precision Oncology Market
- 11.1. Asia-Pacific Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Precision Oncology Market
- 12.1. China Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 12.2. China Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Precision Oncology Market
- 13.1. India Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Precision Oncology Market
- 14.1. Japan Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 14.2. Japan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Precision Oncology Market
- 15.1. Australia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Precision Oncology Market
- 16.1. Indonesia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Precision Oncology Market
- 17.1. South Korea Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 17.2. South Korea Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Precision Oncology Market
- 18.1. Taiwan Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 18.2. Taiwan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Precision Oncology Market
- 19.1. South East Asia Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 19.2. South East Asia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Precision Oncology Market
- 20.1. Western Europe Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 20.2. Western Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Precision Oncology Market
- 21.1. UK Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Precision Oncology Market
- 22.1. Germany Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Precision Oncology Market
- 23.1. France Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Precision Oncology Market
- 24.1. Italy Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Precision Oncology Market
- 25.1. Spain Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Precision Oncology Market
- 26.1. Eastern Europe Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 26.2. Eastern Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Precision Oncology Market
- 27.1. Russia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Precision Oncology Market
- 28.1. North America Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 28.2. North America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Precision Oncology Market
- 29.1. USA Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 29.2. USA Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Precision Oncology Market
- 30.1. Canada Precision Oncology Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 30.2. Canada Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Precision Oncology Market
- 31.1. South America Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 31.2. South America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Precision Oncology Market
- 32.1. Brazil Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Precision Oncology Market
- 33.1. Middle East Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 33.2. Middle East Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Precision Oncology Market
- 34.1. Africa Precision Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 34.2. Africa Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Precision Oncology Market Regulatory and Investment Landscape
36. Precision Oncology Market Competitive Landscape And Company Profiles
- 36.1. Precision Oncology Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
- 36.2. Precision Oncology Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
- 36.3. Precision Oncology Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
37. Precision Oncology Market Other Major And Innovative Companies
- Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
38. Global Precision Oncology Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Precision Oncology Market
40. Precision Oncology Market High Potential Countries, Segments and Strategies
- 40.1 Precision Oncology Market In 2030 - Countries Offering Most New Opportunities
- 40.2 Precision Oncology Market In 2030 - Segments Offering Most New Opportunities
- 40.3 Precision Oncology Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies
41. Appendix
- 41.1. Abbreviations
- 41.2. Currencies
- 41.3. Historic And Forecast Inflation Rates
- 41.4. Research Inquiries
- 41.5. The Business Research Company
- 41.6. Copyright And Disclaimer
